Charlotte Jones-Burton
Direttore/Membro del Consiglio presso BLUEBIRD BIO, INC.
Patrimonio netto: 18 265 $ in data 30/06/2024
Profilo
Charlotte Jones-Burton is the founder of Women of Color in Pharma.
She is currently an Independent Director at bluebird bio, Inc. since 2022 and a Partner & Head of Life Science Product at 2Flo Ventures LLC since 2024.
Previously, she worked as the VP, Global Head-Clinical Development & Nephrology at Otsuka Pharmaceutical Development & Commercialization, Inc. and as the VP-Global Clinical Development & Head-Nephrology at Otsuka Pharmaceuticals (U.K.) Ltd.
From 2022 to 2023, she served as the Senior VP-Product Development & Strategy at Chinook Therapeutics, Inc. Dr. Jones-Burton completed her undergraduate degree at Washington University in St. Louis and holds graduate and doctorate degrees from the University of Maryland School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.01% | 16/06/2023 | 18 562 ( 0.01% ) | 18 265 $ | 30/06/2024 |
Posizioni attive di Charlotte Jones-Burton
| Società | Posizione | Inizio |
|---|---|---|
| BLUEBIRD BIO, INC. | Direttore/Membro del Consiglio | 07/03/2022 |
| Women of Color in Pharma | Fondatore | - |
2 Flo Ventures LLC
 2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | 01/06/2024 |
Precedenti posizioni note di Charlotte Jones-Burton
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 02/10/2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - |
Formazione di Charlotte Jones-Burton
| Washington University in St. Louis | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
2 Flo Ventures LLC
2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Finance |
| Women of Color in Pharma |
- Borsa valori
- Insiders
- Charlotte Jones-Burton
